A cancer metabolism company, is developing first-in-class treatments that aim to prolong the lives of cancer patients by preventing treatment resistance and delaying relapse. Our client of capital raising in China for over 30M.
A new type of bio technology company. Our client of capital raising in Canada and public listing at HKEX to achieve 15B of valuation.
A company conducts research and development in an innovative approach to the treatment of epithelial carcinoma. Our client of capital raising of 20M in China.